880
Participants
Start Date
February 6, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
TL-925
TL-925 is an eye drop.
Placebo
The composition of the vehicle is identical to the active formulation except for the exclusion of the active ingredient.
Scott and Christie EyeCare Associates, Cranberry Township
Piedmont Eye Center, Lynchburg
Oculus Research, Garner
Wilmington Eye, Leland
Advancing Vision Research, Goodlettsville
Advancing Vision Research, Smyrna
Total Eye Care, PA, Memphis
Butchertown Clinical, Louisville
Pankratz Eye, Columbus
Wyse Eyecare, Northbrook
Cornea and Cataract Consultants of Arizona, Phoenix
Nvision - Torrance, Torrance
Global Research Management, Glendale
Nvision - La Mesa, La Mesa
Andover Eye Associates - Andover, Andover
Andover Eye Associates - Raynham, Raynham
NEERA - Westborough, Westborough
NEERA - Woburn, Woburn
Telios Pharma, Inc.
INDUSTRY